Acute diarrhea (in hospitalized adults). A09 ????? ? ???????????? ????? ?? ?? ???? ??????
Conditions
Interventions
Intervention 1: Intervention group: Patients will receive a daily probiotic regimen according to the study protocol. The probiotic is administered in a specific dose and duration as detailed in the pr
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The patient must be an adult (18 years or older). Hospitalized at Bu Ali Sina Hospital, Qazvin due to diarrhea. Diagnosis of diarrhea confirmed by the treating physician. Providing informed consent to participate in the study.
Exclusion criteria
Exclusion criteria: Age less than 18 years (children and adolescents) Not being hospitalized in Bu Ali Sina Hospital, Qazvin. Patients with diarrhea not diagnosed by the responsible physician. Not providing informed consent for participation in the research. Possibility of serious underlying diseases or conditions where probiotic or antibiotic use is contraindicated, according to safety and ethical protocols.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of diarrhea. Timepoint: In this clinical trial, the outcome variables (such as duration of diarrhea, degree of dehydration, number of hospitalizations, and degree of improvement in gastrointestinal symptoms) will be measured at four time points:At baseline (prior to initiation of intervention)Seven days after the start of treatmentFourteen days after the start of treatmentTwenty-one days after the start of treatment. Method of measurement: Data collection procedures:Outcomes will be documented through daily clinical observation, structured patient interviews during follow-ups, and hospital record reviews.Degree of dehydration will be measured via laboratory parameters and clinical signs.Hospitalization count will be sourced from official hospital records.Improvement in gastrointestinal symptoms will be evaluated by stool consistency/frequency, patient complaints, and physician assessment.;Length of hospital stay. Timepoint: In this clinical trial, the outcome variables (such as duration of diarrhea, degree of dehydration, number of hospitalizations, and degree of improvement in gastrointestinal symptoms) will be measured at four time points:At baseline (prior to initiation of intervention)Seven days after the start of treatmentFourteen days after the start of treatmentTwenty-one days after the start of treatment. Method of measurement: Data collection procedures:Outcomes will be documented through daily clinical observation, structured patient interviews during follow-ups, and hospital record reviews.Degree of dehydration will be measured via laboratory parameters and clinical signs.Hospitalization count will be sourced from official hospital records.Improvement in gastrointestinal symptoms will be evaluated by stool consistency/frequency, patient complaints, and physician assessment.;Occurrence of major clinical adverse effects. Timepoint: In this clinical trial, the outcome variables (such as duration of diarrhea, degree of dehydration, number of hospital | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Mohammadi Farahmand
Qazvin University of Medical Sciences
Outcome results
None listed